Method of using PKC inhibiting compounds to treat vascular disease
    1.
    发明授权
    Method of using PKC inhibiting compounds to treat vascular disease 失效
    使用PKC抑制化合物治疗血管疾病的方法

    公开(公告)号:US06228843B1

    公开(公告)日:2001-05-08

    申请号:US09557038

    申请日:2000-04-21

    申请人: Edward C. Dempsey

    发明人: Edward C. Dempsey

    IPC分类号: A01N4304

    CPC分类号: A61K31/365

    摘要: A method for treating pulmonary and systemic vascular diseases associated with cardiac hypotrophy, dysfunction or failure that involves the administration of an effective amount of a PKC antagonist to a patient suffering from one of such diseases is disclosed. PKC antagonists are selected from bryostatin derivatives and more preferably from bryostatin-1. The disease states treatable in accordance with the present invention are characterized by alterations in vascular structure, vascular tone, myocardial hypotrophy, dysfunction or failure, idiopathic pulmonary hypertension and chronic hypoxic pulmonary hypertension. Particular formulations include bryostatin-1 in an effective amount to treat one or more of the above-referenced diseases.

    摘要翻译: 公开了一种用于治疗涉及向患有这些疾病之一的患者施用有效量的PKC拮抗剂的与心脏缩小,功能障碍或失败相关的肺和全身血管疾病的方法。 PKC拮抗剂选自苔藓抑制素衍生物,更优选选自苔藓抑制素-1。 根据本发明可治疗的疾病状态的特征在于血管结构,血管紧张度,心肌缺血,功能障碍或失败,特发性肺动脉高压和慢性缺氧性肺动脉高压的改变。 具体的制剂包括治疗一种或多种上述疾病的有效量的苔藓抑素-1。